2,3-DIMETHYL-2,5-CYCLOHEXADIENE-1,4 DIONE, 95.0%, 1g

(R)-1-(1,4-DIOXAN-2-YL)-N-METHYLMETHANAMINE HCL, 95.0%, 250mg

7-methyl-3,7,11-triazaspiro[5.6]dodecan-12-one dihydrochloride, 95.0%, 1g

3-NITRO-5,6,7,8-TETRAHYDRO-1,6-NAPHTHYRIDINE HCL, 95.0%, 100mg

(2S,4R)-1-((S)-23-Azido-2-(tert-butyl)-4-oxo-6,9,12,15,18,21-hexaoxa-3-azatricosanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide, 98%, 1g

n-Hexane, min. 95%, for synthesis, 2.5 L, glass packaging

2-((Tert-butoxycarbonyl)amino)-3-(3-hydroxyphenyl)propanoic acid, 97%, 500mg

Sodium 2-Naphthol-6-sulfonate>97.0%(HPLC)(T)25g

2-Amino-4-bromobenzothiazole, 98.0%, 100g

METHYL 2,3,5-TRICHLORO-4-METHYLBENZOATE, 95.0%, 5g

tert-Butyl ((6-bromopyridin-2-yl)methyl)carbamate, 95.0%, 100mg

2,6-Dichloro-4-(trifluoromethoxy)aniline, 95.0%, 1g

(2E)-1-(2-chlorophenyl)-3-(3-nitrophenyl)prop-2-en-1-one, 95.0%, 10g